G1 Therapeutics Inc (GTHX)
7.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 18, 16:00
G1 Therapeutics Shareholders Equity (Quarterly): 24.59M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 24.59M |
| March 31, 2024 | 27.74M |
| December 31, 2023 | 35.39M |
| September 30, 2023 | 43.02M |
| June 30, 2023 | 57.55M |
| March 31, 2023 | 44.99M |
| December 31, 2022 | 68.75M |
| September 30, 2022 | 45.96M |
| June 30, 2022 | 66.32M |
| March 31, 2022 | 100.13M |
| December 31, 2021 | 143.54M |
| September 30, 2021 | 178.34M |
| June 30, 2021 | 213.20M |
| March 31, 2021 | 245.44M |
| December 31, 2020 | 177.35M |
| September 30, 2020 | 197.47M |
| Date | Value |
|---|---|
| June 30, 2020 | 203.84M |
| March 31, 2020 | 229.45M |
| December 31, 2019 | 255.53M |
| September 30, 2019 | 286.12M |
| June 30, 2019 | 312.67M |
| March 31, 2019 | 338.94M |
| December 31, 2018 | 358.82M |
| September 30, 2018 | 379.26M |
| June 30, 2018 | 176.52M |
| March 31, 2018 | 183.16M |
| December 31, 2017 | 93.39M |
| September 30, 2017 | 109.13M |
| June 30, 2017 | 123.69M |
| March 31, 2017 | 31.00M |
| December 31, 2016 | 42.59M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
24.59M
Minimum
Jun 2024
255.53M
Maximum
Dec 2019
124.14M
Average
100.13M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| PetIQ Inc | 257.97M |
| Biomarin Pharmaceutical Inc | 5.413B |
| Regeneron Pharmaceuticals Inc | 29.33B |
| Verrica Pharmaceuticals Inc | -34.05M |
| Terns Pharmaceuticals Inc | 218.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.69M |
| Total Liabilities (Quarterly) | 74.10M |
| Debt to Equity Ratio | 1.802 |
| Current Ratio | 2.478 |
| Net Debt Paydown Yield | 5.52% |